ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,002.80
      0.00%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.595
      0.03%
      Bitcoin
      66,843.71
      0.65%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR Esperion Therapeutics Inc

      2.09
      0.00 (0.00%)
      Apr 23 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Esperion Therapeutics Inc ESPR NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 2.09 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      2.09
      more quote information »

      Recent News

      Date Time Source Heading
      4/23/202408:00GLOBEEsperion to Report First Quarter 2024 Financial Results on..
      4/07/202414:45GLOBEEsperion Presents Important New Data from CLEAR Outcomes at..
      4/01/202408:00GLOBEEsperion to Ring Nasdaq Opening Bell Today, April 1, 2024
      3/26/202408:00GLOBEEsperion to Participate in 23rd Annual Needham Virtual..
      3/25/202416:00GLOBEEsperion Announces Data from CLEAR Outcomes Sub-Groups as..
      3/22/202418:26BWU.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL®..
      3/22/202415:10GLOBEU.S. FDA Approves Broad New Labels for NEXLETOL® and..
      3/22/202411:04GLOBECHMP Issues Positive Opinions For Both Bempedoic Acid And..
      2/27/202409:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/27/202407:23EDGAR2Form 8-K - Current report
      2/27/202406:00GLOBEEsperion Reports Fourth Quarter and Full Year 2023 Financial..
      2/16/202416:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
      2/14/202414:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202410:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202408:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202406:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/13/202408:00GLOBEEsperion to Report Fourth Quarter and Full Year 2023..
      2/01/202414:00GLOBERFK, Esperion Therapeutics Announce 2024 Promotional..
      1/23/202416:00GLOBEEsperion Announces Closing of Public Offering of Common..
      1/22/202406:10EDGAR2Form 8-K - Current report
      1/22/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/18/202421:15GLOBEEsperion Announces Pricing of $85.1 Million Public Offering..
      1/18/202416:03EDGAR2Form 8-K - Current report
      1/18/202416:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/18/202416:00GLOBEEsperion Announces Proposed Public Offering of Common Stock
      1/11/202416:09EDGAR2Form 8-K - Current report
      1/03/202415:15BWEsperion e Daiichi Sankyo Europe annunciano un emendamento..
      1/03/202413:54BWEsperion et Daiichi Sankyo Europe annoncent une révision de..
      1/03/202410:07BWEsperion und Daiichi Sankyo Europe geben Anpassung ihrer..
      1/03/202408:00EDGAR2Form 8-K - Current report
      1/03/202407:00BWEsperion and Daiichi Sankyo Europe Announce $125 Million..
      12/18/202308:00GLOBEEsperion to Participate in 42nd Annual J.P. Morgan..
      12/13/202316:46DJNEsperion Therapeutics' Nexletol, Nexlizet Updates Get FDA..
      12/13/202316:00GLOBEU.S. FDA Updates LDL-C Lowering Indication for Esperion’s..
      11/13/202310:30GLOBEEsperion Presents CLEAR Outcomes Analysis of Inflammation as..
      11/11/202311:00GLOBEPartners Announce TRANSFORM Trial to Evaluate Personalized..
      11/09/202316:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
      11/07/202308:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/07/202307:30EDGAR2Form 8-K - Current report
      11/07/202306:00GLOBEEsperion Reports Third Quarter 2023 Financial Results
      10/31/202308:00GLOBEEsperion to Participate in Jefferies London Healthcare..
      10/24/202308:00GLOBEEsperion to Report Third Quarter 2023 Financial Results on..
      10/05/202309:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      9/21/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/20/202315:22EDGAR2Form 144 - Report of proposed sale of securities
      9/12/202310:15GLOBEAmerican College of Cardiology Program to Increase..
      8/28/202308:00GLOBEEsperion to Participate in H.C. Wainwright 25th Annual..
      8/26/202311:00GLOBEEsperion Presents Two CLEAR Outcomes Study Late-Breakers at..
      8/24/202309:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/21/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      ESPR
      Esperion Therapeutics
      Delayed Upgrade Clock